Baxdrostat fits the hypertension type most common in Black adults. Its trial cannot say whether it works for them.
The Food and Drug Administration approved baxdrostat, sold as Baxfendy, on May 15, 2026, the first aldosterone synthase …
6 articles tagged with this topic
The Food and Drug Administration approved baxdrostat, sold as Baxfendy, on May 15, 2026, the first aldosterone synthase …
A validated upper-arm monitor, a cuff sized to your arm, and two readings a minute apart twice a …
The feeding trial that proved an eating pattern can lower blood pressure without weight loss or medication enrolled …
Biotin is what most people reach for when their hair starts shedding, and the short version is this: …
Hypertrophic cardiomyopathy is the most common inherited heart disease and a leading cause of sudden cardiac death in …
Black patients are diagnosed with atrial fibrillation (AFib) less often than White patients, even though they carry more …
One email every Tuesday: essential reporting, a featured provider, and one longread worth your time. Free, no spam, ever.
We'll never share your email. Privacy policy.